Chemoinformaics analysis of 3-Methylbutyl nonanoate
| Molecular Weight | 228.376 | nRot | 10 |
| Heavy Atom Molecular Weight | 200.152 | nRig | 1 |
| Exact Molecular Weight | 228.209 | nRing | 0 |
| Solubility: LogS | -5.504 | nHRing | 0 |
| Solubility: LogP | 5.309 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 43.6542 |
| nHD | 0 | BPOL | 30.6938 |
| QED | 0.411 |
| Synth | 1.813 |
| Natural Product Likeliness | 0.323 |
| NR-PPAR-gamma | 0.015 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.424 |
| Pgp-sub | 0.003 |
| HIA | 0.002 |
| CACO-2 | -4.436 |
| MDCK | 0.0000214 |
| BBB | 0.316 |
| PPB | 0.967051 |
| VDSS | 0.728 |
| FU | 0.025709 |
| CYP1A2-inh | 0.909 |
| CYP1A2-sub | 0.227 |
| CYP2c19-inh | 0.747 |
| CYP2c19-sub | 0.271 |
| CYP2c9-inh | 0.662 |
| CYP2c9-sub | 0.942 |
| CYP2d6-inh | 0.022 |
| CYP2d6-sub | 0.05 |
| CYP3a4-inh | 0.295 |
| CYP3a4-sub | 0.144 |
| CL | 9.867 |
| T12 | 0.481 |
| hERG | 0.109 |
| Ames | 0.005 |
| ROA | 0.053 |
| SkinSen | 0.929 |
| Carcinogencity | 0.142 |
| EI | 0.981 |
| Respiratory | 0.615 |
| NR-Aromatase | 0.015 |
| Antiviral | Yes |
| Prediction | 0.779239 |